Kenvue CEO Discusses Growth Outlook After J&J Unit Jumps 20% in Market Debut
Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.
Domino’s Pizza reported a 7.1% revenue rise to $1.1B amid value meal competition and inflation. Q3 may slow, with caution on growth and consumer spending.
Vanguard's "How America Saves" report analyzes U.S. retirement trends, focusing on 401(k) plans, including automatic enrollment and contribution rates.